Effects of Guided Written Disclosure Protocol on Psychological Distress and Positive Functioning in Persons With Skin Diseases: a Randomized-controlled Trial

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Psychological DistressEmotional StressSkin DiseasesDisclosure
Interventions
BEHAVIORAL

Guided Written Disclosure Protocol Group

The writing task consists of three sessions of 20 minutes each, with an interval of one week between each other. In the first session, patients were asked to describe the onset of illness, describing chronologically and detailed places, images, sounds and actions, as they are followed and detached from the emotions. In the second session, the patients were asked to write about thoughts and emotions felt during the illness experience, talking about the impact that illness had on their daily lives and how it had changed their personal attitude to life itself. In the third and final session, the patients were asked to analyze subjective new skills acquired.

BEHAVIORAL

Active Control Group

The writing task also consists of three sessions of 20 minutes each, with an interval of one week between each other. In all three writing sessions, patients were asked to report the daily activities during the last week, without focusing on the emotional aspects.

Trial Locations (1)

00167

IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monti, Rome

All Listed Sponsors
collaborator

IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monti

OTHER

lead

European University of Rome

OTHER

NCT04739228 - Effects of Guided Written Disclosure Protocol on Psychological Distress and Positive Functioning in Persons With Skin Diseases: a Randomized-controlled Trial | Biotech Hunter | Biotech Hunter